Clinical Trial Update: Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

View source ↗

Summary

Clinical trial update for an international registry evaluating the effectiveness of SGLT2 inhibitors in adults with congenital heart disease; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Congenitally Corrected Transposition of the Great Arteries
• Fontan Circulation
• Single Ventricle
• Systemic Right Ventricle
• Tetralogy of Fallot
• Transposition of the Great Arteries

Drugs mentioned

• FARXIGA (dapagliflozin)
• INVOKANA (CANAGLIFLOZIN)
• Jardiance (empagliflozin)
• STEGLATRO (ertugliflozin)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Adult Congenital Heart Disease, Congenital Heart Disease | Status: RECRUITING